Prostate cancer treatment recommendation study based on machine learning and SHAP interpreter
Cancer Science · 2024
DOI: 10.1111/cas.16327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Shengsheng Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Machine Learning, SEER Program, Prostatectomy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Key Research and Development Program of China, the Guangdong Natural Science Foundation, the Guangzhou Science and Technology Plan Project.
Abstract (Originalsprache)
This study utilized data from 140,294 prostate cancer cases from the Surveillance, Epidemiology, and End Results (SEER) database. Here, 10 different machine learning algorithms were applied to develop treatment options for predicting patients with prostate cancer, differentiating between surgical and non‐surgical treatments. The performances of the algorithms were measured using the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, positive predictive value, negative predictive value. The Shapley Additive Explanations (SHAP) method was employed to investigate the key factors influencing the prediction process. Survival analysis methods were used to compare the survival rates of different treatment options. The CatBoost model yielded the best results (AUC = 0.939, sensitivity = 0.877, accuracy = 0.877). SHAP interpreters revealed that the T stage, cancer stage, age, cores positive percentage, prostate‐specific antigen, and Gleason score were the most critical factors in predicting treatment options. The study found that surgery significantly improved survival rates, with patients undergoing surgery experiencing a 20.36% increase in 10‐year survival rates compared with those receiving non‐surgical treatments. Among surgical options, radical prostatectomy had the highest 10‐year survival rate at 89.2%. This study successfully developed a predictive model to guide treatment decisions for prostate cancer. Moreover, the model enhanced the transparency of the decision‐making process, providing clinicians with a reference for formulating personalized treatment plans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Medical Big-Data Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
- Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Yi Zhou
Förderung
- the Key Research and Development Program of China
- the Guangdong Natural Science Foundation
- the Guangzhou Science and Technology Plan Project
- the Fundamental Research Funds for the Central Universities of Sun Yat-sen University
- the Key Research and Development Programs of Jiangxi Provincial Department of Science and Technology
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Tang, S., Zhang, H., Liang, J., Tang, S., Li, L., Li, Y., Xu, Y., Wang, D., & Zhou, Y. (2024). Prostate cancer treatment recommendation study based on machine learning and SHAP interpreter. Cancer Science. https://doi.org/10.1111/cas.16327
Vancouver
Tang S, Zhang H, Liang J, Tang S, Li L, Li Y, et al. Prostate cancer treatment recommendation study based on machine learning and SHAP interpreter. Cancer Science. 2024. doi:10.1111/cas.16327
BibTeX
@article{Tang2024,
author = {Tang, Shengsheng and Zhang, Hongzheng and Liang, Junhao and Tang, Shishi and Li, Lin and Li, Yuxuan and Xu, Yuan and Wang, Daohu and Zhou, Yi},
title = {Prostate cancer treatment recommendation study based on machine learning and SHAP interpreter},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16327}
}
EUVIMED